Cerity Partners
GMOV

Cerity Partners’s GMO US Value ETF GMOV Stock Holding History

Cerity Partners’s Portfolio GMOV Stock Details GMOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
46,784
-6,685
-13% -$198K ﹤0.01% 1785
2026
Q1 		$1.5M Sell
53,469
-44,260
-45% -$1.26M ﹤0.01% 1633
2025
Q4 		$2.69M Hold
97,729
– – ﹤0.01% 1241
2025
Q3 		$2.58M Hold
97,729
– – ﹤0.01% 1170
2025
Q2 		$2.47M Hold
97,729
– – ﹤0.01% 1118
2025
Q1 		$2.4M Hold
97,729
– – ﹤0.01% 1028
2024
Q4 		$2.39M Buy
+97,729
New +$2.47M 0.01% 1024

Other funds holding GMOV

CA
Commerce Advisors Memphis, Tennessee $184M AUM
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
LCWP
Legacy Capital Wealth Partners Little Rock, Arkansas $521M AUM 28.27% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $217M AUM 47.35% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Cerity Partners's GMOV Position: Q2 2026 in Review

Cerity Partners reduced its GMO US Value ETF (GMOV) stake by 13% in Q2 2026, selling an estimated $198K and leaving 46,784 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

Cerity Partners first reported a position in GMOV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.69M in Q4 2025. 19 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.

  • Cerity Partners held 46,784 shares of GMO US Value ETF worth $1.39M as of Q2 2026.
  • Cerity Partners sold 6,685 GMO US Value ETF shares in Q2 2026, an estimated $198K.
  • GMO US Value ETF made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1785 holding.
  • Cerity Partners first reported a position in GMO US Value ETF in Q4 2024 and has held it in 7 quarters since.
  • Cerity Partners's GMO US Value ETF position peaked at $2.69M in Q4 2025.
  • 19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.